← 返回列表 › SCI 期刊 › 医学 › EJSO-EUR J SURG ONC

Ejso

EJSO-EUR J SURG ONC

Print ISSN 0748-7983 Online ISSN 1532-2157
SCIE Q1 新锐3区 传统2区 混合OA 医学
影响因子 2026
3.5
↑ 0.6
5年均分
3.6
5-Year IF
H 指数
89
H-Index
年发文量
232
Articles / Year
出刊频率
Monthly
Pub. Frequency
创刊年份
1985
Founded Year
出版商
Elsevier Sci Ltd
Publisher
出版国家
UK
Country
投稿参考 & 用户评分
🏆 期刊声誉
★★★★★
暂无
综合口碑评分,点击星星参与
⚡ 审稿速度
★★★★★
系统
暂无
约 1.8 个月
💰 版面费用
★★★★★
系统
暂无
官方APC $3,570 USD 约¥25,883
中科院分区
2026新锐分区 新体系
大类3区
医学Medicine
小类3区
肿瘤学Oncology
中科院2025年分区 传统体系
大类2区
医学Medicine
小类2区
肿瘤学Oncology
WoS 期刊 JCR 分区 (2026 · JIF) 综合 SCIE Q1
学科 收录集 JIF 分区 JIF 排名 JIF 百分位
外科学 Surgery SCIE Q1 47/321
85.4%
肿瘤学 Oncology SCIE Q2 142/333
57.4%
按 JCI 指标学科分区
学科 收录集 JCI 分区 JCI 排名 JCI 百分位
外科学 Surgery SCIE Q1 44/269 JCI 1.22
84.0%
肿瘤学 Oncology SCIE Q1 45/268 JCI 1.22
83.6%
Scopus 指标
CiteScore
6.2
综合引用得分
SJR
1.057 Q1
SCImago Journal Rank
SNIP
1.262
Source Normalized Impact
JCI
1.22
Journal Citation Indicator
数据来源:Scopus (CiteScore · SJR · SNIP) · Clarivate (JCI)。指标年份:2026年6月最新版。
期刊简介

EJSO, officially abbreviated as EJSO-EUR J SURG ONC and carrying the ISSN 0748-7983, is a premier, peer-reviewed international journal dedicated to advancing the science and practice of surgical oncology. Published by Elsevier, the journal serves as a vital resource for surgeons, oncologists, clinical researchers, and multidisciplinary cancer care teams. Its scope encompasses the full spectrum of surgical oncology, including the management of solid tumors, innovative surgical techniques, perioperative care, and the integration of surgery with systemic therapies and radiotherapy. EJSO publishes a diverse range of article types, including original research articles, comprehensive reviews, meta-analyses, editorials, and rapid communications, with a strong emphasis on high-quality clinical studies that directly impact patient outcomes. Notable features include options for open access, ensuring broad dissemination of groundbreaking findings, and a rigorous peer-review process that maintains the journal’s high academic standard. With an Impact Factor of 3.5000 (projected for 2026) and a distinguished JCR Quartile ranking of Q1, EJSO stands as a top-tier journal in the field of surgery and oncology. This esteemed position reflects its consistent publication of influential research and its role as a benchmark for clinical excellence and innovation, making it an essential platform for surgeons and researchers seeking to shape the future of cancer treatment.

历年影响因子 & 年发文量

上述信息均来源于网络,以官方发布为准,仅供参考。如有建议,欢迎反馈

生物行 © 2002–2026  All Rights Reserved.